Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
02/14/20 | Statement of changes in beneficial ownership of securities | 2 | |||
02/14/20 | Statement of changes in beneficial ownership of securities | 2 | |||
02/14/20 | Statement of changes in beneficial ownership of securities | 2 | |||
02/14/20 | Statement of changes in beneficial ownership of securities | 2 | |||
02/14/20 | Statement of changes in beneficial ownership of securities | 2 | |||
12/19/19 | Statement of changes in beneficial ownership of securities | 1 | |||
12/19/19 | Statement of changes in beneficial ownership of securities | 1 | |||
12/19/19 | Statement of changes in beneficial ownership of securities | 1 | |||
08/09/19 | Statement of changes in beneficial ownership of securities | 1 | |||
08/09/19 | Statement of changes in beneficial ownership of securities | 1 |